Black Rock Mining Reports Excellent Ulanzi Results


Published 27-APR-2016 13:00 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Black Rock Mining (ASX:BKT) continues to deliver excellent results as it further explores for graphite in Tanzania at its Mahenge Project.

Tanzania is a highly volatile area with severe jurisdictional risk.

Optimisation work in the Ulanzi Graphite Resource area at Mahenge on bulk samples continues to deliver incremental improvements to graphite purity and flake sizing.

Further testing currently being undertaken is expected to see significant additional improvements.

The results have shown up to 98.2% purity for its resources coarsest fractions.

The entire +75 to +500 micron portion of flake graphite is now achieving >97.1% TGC (Total Graphitic Carbon) purity. This represents 98.3% of all graphite produced.

The Ulanzi bulk sample has a bias towards coarse sizing, with 66.3% of the flake graphite produced through test work showing >180 microns in size (coarse, jumbo and super jumbo sizing).

This size fraction typically receives a price premium to finer flake, meaning there is potential to improve the basket pricing from the scoping study where 50% coarse sizing was assumed.

In the coming months, further metallurgical samples will be sent from Tanzania to test additional portions of the Ulanzi and Cascade lodes.

Two bulk surface samoles and rill core samples are currently being prepared.

Further test work will determine chemically upgraded purity and the suitability of Mahenge graphite flake for a suite of value added applications including expanded graphite, expandable graphite, spherical graphite test work and other industrial applications.

The metallurgical programme will continue for up to six months in parallel with Pre-Feasibility and Bank Feasibility studies.

The ongoing metallurgical programme continues to deliver significant improvements in purity and flake size for the Company to optimise a process flowsheet,” said Black Rock Mining Managing Director Steve Tambanis.”

“Results indicate that Mahenge graphite can manufacture premium flake products from a straightforward flotation circuit and there is scope for additional improvements.”

Mr Tambanis will announce additional results in coming months with regard to process optimisation and expandable, spherical and battery testing.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free